<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Excitotoxic Neurons</th>
</tr>
<tr>
<td class="label">Taxonomy</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Target</td>
<td>Agent</td>
</tr>
<tr>
<td class="label">NMDA antagonists</td>
<td>Memantine</td>
</tr>
<tr>
<td class="label">NMDA antagonists</td>
<td>Dextrorphan</td>
</tr>
<tr>
<td class="label">AMPA antagonists</td>
<td>Perampanel</td>
</tr>
<tr>
<td class="label">mGluR5 negative allosteric modulators</td>
<td>CTEP</td>
</tr>
<tr>
<td class="label">GABA-A agonists</td>
<td>Benzodiazepines</td>
</tr>
</table>
Excitotoxic neurons are neurons experiencing excessive glutamate receptor activation, leading to calcium influx, oxidative stress, and ultimately cell death. This process is implicated in acute brain injury (stroke, traumatic brain injury) and chronic neurodegenerative diseases including Alzheimer's disease, Parkinson's disease, Huntington's disease, and amyotrophic lateral sclerosis (ALS)[@olney1969].
<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Excitotoxic Neurons</th>
</tr>
<tr>
<td class="label">Taxonomy</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Target</td>
<td>Agent</td>
</tr>
<tr>
<td class="label">NMDA antagonists</td>
<td>Memantine</td>
</tr>
<tr>
<td class="label">NMDA antagonists</td>
<td>Dextrorphan</td>
</tr>
<tr>
<td class="label">AMPA antagonists</td>
<td>Perampanel</td>
</tr>
<tr>
<td class="label">mGluR5 negative allosteric modulators</td>
<td>CTEP</td>
</tr>
<tr>
<td class="label">GABA-A agonists</td>
<td>Benzodiazepines</td>
</tr>
</table>
Excitotoxic neurons are neurons experiencing excessive glutamate receptor activation, leading to calcium influx, oxidative stress, and ultimately cell death. This process is implicated in acute brain injury (stroke, traumatic brain injury) and chronic neurodegenerative diseases including Alzheimer's disease, Parkinson's disease, Huntington's disease, and amyotrophic lateral sclerosis (ALS)[@olney1969].
Excitotoxicity was first described by Olney in 1969 as a phenomenon where excess glutamate causes neuronal damage. The process involves overactivation of ionotropic glutamate receptors (NMDA, AMPA, and kainate receptors), leading to pathological calcium influx into neurons["@choi1992"]. This triggers a cascade of destructive cellular events including activation of proteolytic enzymes, mitochondrial dysfunction, generation of reactive oxygen species (ROS), and ultimately neuronal death through both apoptotic and necrotic mechanisms["@bano2007"].
The blood-brain barrier (BBB) normally protects the brain from systemic glutamate, but in pathological conditions, glutamate can accumulate extracellularly from presynaptic terminals, reversed glutamate transporters, or through BBB disruption. Astrocytic glutamate transporters (EAAT1/GLAST and EAAT2/GLT-1) normally maintain extracellular glutamate at micromolar concentrations, but these systems can become overwhelmed or dysfunctional in disease states["@danbolt2001"].
<!-- multi-taxonomy-enrichment -->
The calcium dysregulation in excitotoxicity follows a characteristic sequence:
The calcium overload activates multiple destructive enzymatic pathways:
Certain neuronal populations exhibit heightened excitotoxic vulnerability:
Neurons possess intrinsic protective mechanisms against excitotoxicity:
In acute ischemic stroke, cessation of blood flow leads to energy failure, membrane depolarization, and massive glutamate release from ischemic neurons. This triggers fulminant excitotoxicity that can expand the infarct core into the penumbra. Similarly, traumatic brain injury causes mechanical disruption leading to glutamate release and excitotoxic secondary injury[@dirnagl1999].
Multiple mechanisms link excitotoxicity to AD pathophysiology:
Excitotoxic mechanisms contribute to dopaminergic neuron loss in PD:
Huntington disease shows striking excitotoxic vulnerability:
ALS demonstrates cortical hyperexcitability:
Current research focuses on:
The study of Excitotoxic Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
The following diagram shows the key molecular relationships involving Excitotoxic Neurons discovered through SciDEX knowledge graph analysis: